Home › Chronic Kidney Disease › District of Columbia
Chronic Kidney Disease clinical trials in District of Columbia
5 studies for Chronic Kidney Disease are looking for participants at sites in District of Columbia.
Cities in District of Columbia
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06742723A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
- Research Site, Washington D.C.
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Sep 24, 2026 · NCT07624305Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity
- Georgetown University, Washington D.C.
Recruiting
Ages 55 and older · All sexes · Updated Sep 8, 2026 · NCT05655325Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD
- Washington DC Veterans Affairs Medical Center (688), Washington D.C.
RecruitingPhase 4
Ages 19 to 90 · All sexes · Updated Aug 21, 2026 · NCT06110130A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities
- Unity Health Care, Washington D.C.
Recruiting
Ages 18 and older · All sexes · Updated Oct 9, 2025 · NCT05321368From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.